StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
227
This month
2
This year
8
Publishing Date
2023 - 10 - 31
2
2023 - 10 - 18
2
2023 - 09 - 08
2
2023 - 08 - 08
2
2023 - 06 - 15
2
2023 - 05 - 09
2
2023 - 04 - 04
2
2022 - 12 - 16
4
2022 - 11 - 01
2
2022 - 09 - 16
2
2022 - 09 - 13
2
2022 - 07 - 26
2
2022 - 07 - 19
2
2022 - 04 - 18
2
2022 - 02 - 14
2
2022 - 01 - 04
2
2021 - 12 - 31
2
2021 - 11 - 26
2
2021 - 11 - 20
2
2021 - 11 - 17
2
2021 - 11 - 01
2
2021 - 09 - 23
2
2021 - 08 - 05
2
2021 - 06 - 17
2
2021 - 06 - 11
2
2021 - 06 - 10
1
2021 - 06 - 09
2
2021 - 06 - 07
1
2021 - 06 - 04
1
2021 - 05 - 27
1
2021 - 05 - 24
1
2021 - 05 - 21
1
2021 - 05 - 20
1
2021 - 05 - 11
1
2021 - 05 - 10
1
2021 - 05 - 05
1
2021 - 05 - 03
1
2021 - 04 - 23
2
2021 - 04 - 14
1
2021 - 04 - 13
1
2021 - 04 - 08
1
2021 - 04 - 05
1
2021 - 03 - 15
1
2021 - 03 - 08
1
2021 - 03 - 01
1
2021 - 02 - 26
1
2021 - 02 - 22
1
2021 - 02 - 18
1
2021 - 02 - 16
2
2021 - 02 - 04
3
2021 - 02 - 02
2
2021 - 01 - 28
1
2021 - 01 - 22
2
2021 - 01 - 15
1
2021 - 01 - 07
1
2021 - 01 - 06
1
2020 - 12 - 28
1
2020 - 12 - 21
1
2020 - 12 - 17
2
2020 - 12 - 09
1
Sector
Consumer durables
1
Consumer services
1
Distribution services
1
Electronic technology
1
Energy minerals
1
Finance
1
Health care and social assistance
1
Health technology
227
Manufacturing
2
N/a
2
Non-energy minerals
1
Process industries
2
Producer manufacturing
1
Retail trade
1
Technology services
3
Utilities
1
Tags
Agreement
2
Alliances
3
Antibody
3
Application
4
Approval
10
Approved
4
Australia
4
Authorization
24
Authorized
5
Awards
3
Biocapital
29
Biopharma
3
Bioscience
2
Biotech
2
Biotechnology
22
Canada
3
Candidate
2
Chmp
3
Clinical-trials-phase-ii
3
Clinical-trials-phase-iii
4
Conference
26
Congress
2
Covid
67
Covid-19
93
Deadline
5
Disease
7
Earnings
6
Emergency use authorization
10
Europe
9
Events
9
Fda
11
Financial
10
Financial results
7
Global
3
Grant
5
Granted
8
Grants
3
Health
7
India
10
Influenza
7
License
3
Merge
9
N/a
131
Nuvaxovid
3
Nvx-cov2373
5
Offering
6
People
4
Phase 2
5
Phase 2b
3
Phase 3
13
Positive
6
Product-news
3
Prototype
5
Research
10
Results
27
Submission
5
Switzerland
3
Trial
20
Vaccine
132
World
3
Entities
Abbott laboratories
1
Alector, inc.
1
Arcturus therapeutics holdings inc.
1
Ardelyx, inc.
1
Arrival
1
Astellas pharma inc
1
Astrazeneca plc
4
Baxter international inc.
1
Biogen inc.
2
Biontech se
3
Bristol-myers squibb company
1
Cidara therapeutics, inc.
1
Codexis, inc.
1
Emergent biosolutions, inc.
1
Endo international plc
1
Glaxosmithkline plc
4
Henry schein, inc.
1
Icosavax inc
1
Immunocellular therapeutics, ltd.
1
Inovio pharmaceuticals, inc.
1
Johnson & johnson
16
Legend biotech corporation
1
Lordstown motors corp.
1
Mks instruments, inc.
1
Moderna, inc.
9
Modivcare inc
1
Morgan stanley
1
Msci inc
1
Mueller industries, inc.
1
Netflix, inc.
1
Neurocrine biosciences, inc.
1
Newmont corporation
1
Nkarta, inc.
1
Novartis ag
1
Novavax, inc.
227
Nrg energy, inc.
1
Nutanix, inc.
1
Nutrien ltd.
1
Oge energy corp
1
Olympic steel, inc.
1
Omnicell, inc.
1
Ovintiv inc.
1
Par pacific holdings, inc.
1
Paycom software, inc.
1
Paypal holdings, inc.
1
Penumbra, inc.
1
Pfizer, inc.
2
Pinterest, inc.
1
Qualcomm incorporated
1
Rayonier advanced materials inc.
1
Regeneron pharmaceuticals, inc.
1
Relmada therapeutics, inc.
1
Renewable energy group, inc.
1
Renovacor, inc.
2
Sanofi
18
Snap inc.
1
Soligenix, inc.
1
Stoneco ltd.
1
Takeda pharmaceutical company limited
4
Walmart inc.
1
Symbols
AAPL
1198
ABB
1433
ABBV
1029
ABLZF
1172
ABT
1795
ACN
602
AMGN
744
ARVL
4301
AVGO
597
AZN
667
BDX
796
BMY
662
BNPQF
1765
BNPQY
1765
CSCO
899
DHR
785
ERIC
1614
F
643
FNCTF
7207
FRBA
600
GE
918
GLAXF
661
GOOG
1294
GOOGL
1293
GSK
887
HON
1791
HUBS
1400
IBM
655
INTC
955
IT
595
JNJ
4590
LLY
1710
LTUM
971
LYV
717
MDT
1285
MMM
938
MS
4289
MSFT
1202
MT
591
NOK
902
NOKBF
978
NVO
634
NVS
1243
NVSEF
1033
ORCL
1160
PCRFF
651
PCRFY
651
PFE
693
PHG
963
PPRUF
1129
PPRUY
1130
SAP
1480
SAPGF
1234
SNOW
796
SNY
4546
SNYNF
3604
TEVJF
632
TMO
1626
VZ
1218
XYF
678
Exchanges
Nasdaq
227
Nyse
23
Crawled Date
2023 - 10 - 31
2
2023 - 10 - 18
2
2023 - 09 - 08
2
2023 - 08 - 08
2
2023 - 06 - 15
2
2023 - 05 - 09
2
2023 - 04 - 04
2
2022 - 12 - 16
4
2022 - 11 - 01
2
2022 - 09 - 16
2
2022 - 09 - 13
2
2022 - 07 - 26
2
2022 - 07 - 19
2
2022 - 04 - 18
2
2022 - 02 - 14
2
2022 - 02 - 11
2
2022 - 01 - 04
2
2021 - 12 - 31
2
2021 - 11 - 26
2
2021 - 11 - 17
2
2021 - 11 - 01
2
2021 - 09 - 23
2
2021 - 08 - 05
2
2021 - 06 - 11
2
2021 - 06 - 10
1
2021 - 06 - 09
2
2021 - 06 - 07
1
2021 - 06 - 05
1
2021 - 05 - 27
1
2021 - 05 - 24
1
2021 - 05 - 21
1
2021 - 05 - 20
1
2021 - 05 - 11
1
2021 - 05 - 10
1
2021 - 05 - 06
1
2021 - 05 - 03
1
2021 - 04 - 24
1
2021 - 04 - 23
1
2021 - 04 - 14
1
2021 - 04 - 13
1
2021 - 04 - 08
1
2021 - 04 - 05
1
2021 - 03 - 15
1
2021 - 03 - 08
1
2021 - 03 - 01
1
2021 - 02 - 26
1
2021 - 02 - 22
1
2021 - 02 - 18
1
2021 - 02 - 16
2
2021 - 02 - 04
3
2021 - 02 - 02
2
2021 - 01 - 28
1
2021 - 01 - 22
2
2021 - 01 - 15
1
2021 - 01 - 08
1
2021 - 01 - 06
1
2020 - 12 - 28
1
2020 - 12 - 21
1
2020 - 12 - 17
2
2020 - 12 - 09
1
Crawled Time
00:00
3
00:20
4
01:00
7
02:00
2
03:00
2
04:20
2
05:00
4
06:00
2
07:00
1
08:00
2
10:00
2
11:00
7
12:00
13
12:03
1
12:15
1
12:20
6
12:30
1
12:57
1
13:00
18
13:03
3
13:15
3
13:20
5
13:30
2
14:00
21
14:03
1
14:15
1
14:20
3
14:30
6
15:00
12
15:20
3
15:30
2
16:00
8
16:20
2
17:00
5
18:00
7
19:00
10
20:00
6
21:00
14
21:03
2
22:00
15
22:01
2
23:00
14
23:01
1
Source
www.biospace.com
96
www.fda.gov
1
www.globenewswire.com
20
www.prnewswire.com
110
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
symbols :
NVAX
save search
Codexis Announces Appointment of Rahul Singhvi, Sc.D., to Board of Directors
Published:
2022-10-03
(Crawled : 13:00)
- biospace.com/
IMUC
|
$0.1979
97.3%
210
|
n/a
|
-76.19%
|
O:
-14.88%
H:
23.08%
C:
23.08%
NVAX
|
$4.09
3.02%
2.93%
2.3M
|
Health Technology
|
-77.64%
|
O:
0.82%
H:
3.22%
C:
1.36%
CDXS
|
$2.86
1.06%
1.05%
200K
|
Process Industries
|
-52.81%
|
O:
1.32%
H:
0.33%
C:
-1.14%
Worldwide Vaccine Industry to 2027 - Key Drivers, Restraints and Opportunities
Published:
2021-10-13
(Crawled : 19:00)
- prnewswire.com
ALPMY
|
News
|
$9.5
-1.11%
1M
|
Manufacturing
|
-44.33%
|
O:
1.46%
H:
0.0%
C:
-0.4%
JNJ
|
News
|
$149.12
0.82%
0.0%
9.3M
|
Health Technology
|
-6.33%
|
O:
0.32%
H:
0.9%
C:
0.25%
GSK
|
News
|
$40.59
2.11%
-0.36%
3.8M
|
Health Technology
|
4.61%
|
O:
0.28%
H:
0.06%
C:
-0.49%
SNY
|
News
|
$47.125
1.78%
1.75%
2.1M
|
Health Technology
|
-4.03%
|
O:
1.2%
H:
0.08%
C:
-0.43%
NVAX
|
$4.09
3.02%
2.93%
2.3M
|
Health Technology
|
-97.55%
|
O:
2.18%
H:
2.72%
C:
-0.16%
vaccine
BioSpace Movers & Shakers, April 1
Published:
2022-04-01
(Crawled : 15:00)
- biospace.com/
RCOR
|
$3.2
0.0%
|
|
-24.53%
|
O:
0.0%
H:
3.19%
C:
-4.01%
WMT
|
News
|
$60.14
1.03%
-0.23%
15M
|
Retail Trade
|
-59.62%
|
O:
0.5%
H:
1.08%
C:
0.9%
NVS
|
News
|
$95.12
0.81%
-1.18%
2.4M
|
Health Technology
|
8.0%
|
O:
-0.64%
H:
0.6%
C:
0.57%
JNJ
|
News
|
$149.12
0.82%
0.0%
9.3M
|
Health Technology
|
-16.94%
|
O:
-1.39%
H:
0.0%
C:
0.0%
BMY
|
$49.14
0.43%
0.0%
7.9M
|
Health Technology
|
-32.71%
|
O:
0.22%
H:
1.01%
C:
0.86%
ABT
|
News
|
$107.07
-0.2%
0.0%
4.9M
|
Health Technology
|
-9.54%
|
O:
0.41%
H:
0.11%
C:
-0.22%
SNY
|
News
|
$47.125
1.78%
1.75%
2.1M
|
Health Technology
|
-10.53%
|
O:
-0.31%
H:
0.0%
C:
0.0%
NVAX
|
$4.09
3.02%
2.93%
2.3M
|
Health Technology
|
-94.47%
|
O:
-0.48%
H:
4.07%
C:
1.39%
NKTX
|
$7.39
1.37%
1.35%
830K
|
Health Technology
|
-35.06%
|
O:
-1.23%
H:
4.98%
C:
1.78%
ALEC
|
$5.18
1.77%
1.74%
350K
|
Health Technology
|
-63.72%
|
O:
-0.21%
H:
2.39%
C:
-1.05%
Global Coronavirus (COVID-19) Vaccines Markets, 2019-2020 & 2027: Inactivated Virus, Protein Subunit, Non-replicating Viral Vector, Repurposed, RNA, DNA, Genetics
Published:
2021-06-04
(Crawled : 00:20)
- prnewswire.com
NVAX
|
$4.09
3.02%
2.93%
2.3M
|
Health Technology
|
Email alert
Add to watchlist
ARCT
4
|
$27.07
4.2%
4.03%
310K
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
News
|
$47.125
1.78%
1.75%
2.1M
|
Health Technology
|
Email alert
Add to watchlist
BNTX
|
News
|
$88.01
1.38%
1.36%
390K
|
Health Technology
|
Email alert
Add to watchlist
MRNA
|
News
S
|
$104.48
3.03%
2.94%
3.1M
|
Health Technology
|
Email alert
Add to watchlist
AZN
|
News
|
$70.12
2.29%
2.24%
4.8M
|
Health Technology
|
Email alert
Add to watchlist
JNJ
|
News
|
$149.12
0.82%
0.0%
9.3M
|
Health Technology
|
Email alert
Add to watchlist
covid
genetic
vaccine
repurposed
Global Vaccines Market Research Report 2022-2027: A $200+ Billion Industry - Forecasts, Company Market Share and Expert Market Estimates for Vaccine Categories
Published:
2023-02-08
(Crawled : 16:00)
- prnewswire.com
PFE
|
News
A
|
$26.26
1.0%
-0.08%
36M
|
Health Technology
|
-39.76%
|
O:
-0.09%
H:
1.26%
C:
0.99%
JNJ
|
News
|
$149.12
0.82%
0.0%
9.3M
|
Health Technology
|
-8.74%
|
O:
-0.06%
H:
0.77%
C:
0.19%
EBS
|
News
|
$2.16
5.88%
0.0%
1.4M
|
Health Technology
|
-84.68%
|
O:
-0.78%
H:
0.79%
C:
-5.29%
SNGX
|
$0.408
-5.34%
-5.64%
620K
|
Health Technology
|
-93.93%
|
O:
-0.07%
H:
4.9%
C:
2.27%
SNY
|
News
|
$47.125
1.78%
1.75%
2.1M
|
Health Technology
|
-0.03%
|
O:
3.05%
H:
0.0%
C:
0.0%
NVAX
|
$4.09
3.02%
2.93%
2.3M
|
Health Technology
|
-62.63%
|
O:
0.0%
H:
1.74%
C:
-4.13%
INO
|
$10.005
3.36%
3.25%
330K
|
Health Technology
|
438.71%
|
O:
-1.61%
H:
2.73%
C:
-8.47%
BNTX
|
News
|
$88.01
1.38%
1.36%
390K
|
Health Technology
|
-38.07%
|
O:
-1.35%
H:
1.53%
C:
0.68%
research
global
report
vaccine
market
Top MNCs lauded by Frost and Sullivan Institute for their Commitment to ESG with Enlightened Growth Leadership Awards 2022
Published:
2022-09-30
(Crawled : 15:20)
- prnewswire.com
MODV
4
|
$21.95
3.25%
3.14%
200K
|
Health Care and Social Assistan...
|
-78.33%
|
O:
-0.69%
H:
3.21%
C:
-1.11%
RYAM
4
|
$4.2
-2.33%
0.0%
450K
|
Process Industries
|
26.89%
|
O:
-1.21%
H:
3.67%
C:
-3.67%
PINS
S
|
$32.73
1.02%
-0.67%
5.6M
|
Technology Services
|
41.14%
|
O:
-0.82%
H:
3.74%
C:
1.3%
PAYC
4
|
$186.71
1.89%
0.0%
470K
|
Technology Services
|
-44.17%
|
O:
-0.21%
H:
2.15%
C:
-1.12%
PARR
|
$32.28
1.64%
0.0%
580K
|
Energy Minerals
|
103.15%
|
O:
-1.51%
H:
6.39%
C:
4.86%
OVV
|
$52.18
0.39%
-0.02%
2M
|
Energy Minerals
|
14.63%
|
O:
-1.43%
H:
3.87%
C:
2.52%
OGE
|
$34.04
-0.03%
0.0%
2.2M
|
Utilities
|
-9.03%
|
O:
0.59%
H:
0.32%
C:
-3.13%
NTR
|
$52.3
-0.91%
0.0%
950K
|
Process Industries
|
-37.43%
|
O:
-0.67%
H:
2.38%
C:
0.43%
NRG
|
$70.39
0.6%
0.17%
2.7M
|
Utilities
|
79.66%
|
O:
0.51%
H:
0.46%
C:
-2.82%
NEM
|
News
|
$37.46
-4.0%
-0.08%
14M
|
Non-Energy Minerals
|
-10.3%
|
O:
0.05%
H:
2.27%
C:
0.6%
MLI
4
|
$53.54
2.41%
0.0%
620K
|
Producer Manufacturing
|
-9.82%
|
O:
0.15%
H:
2.69%
C:
-0.03%
MSCI
|
$515.17
1.0%
0.2%
910K
|
Technology Services
|
21.73%
|
O:
-0.26%
H:
2.13%
C:
-0.08%
REGN
|
News
|
$899.71
0.32%
0.32%
340K
|
Health Technology
|
30.11%
|
O:
0.37%
H:
1.15%
C:
-0.8%
QCOM
|
$160.15
1.6%
1.57%
7.5M
|
Electronic Technology
|
39.48%
|
O:
-0.94%
H:
2.22%
C:
-0.69%
PYPL
A
|
$63.19
1.41%
1.39%
9.9M
|
Technology Services
|
-28.76%
|
O:
-0.85%
H:
1.79%
C:
-2.14%
OMCL
|
News
|
$28.21
1.37%
1.35%
450K
|
Technology Services
|
-67.92%
|
O:
0.17%
H:
3.06%
C:
-1.09%
ZEUS
|
$67.84
-0.04%
-0.04%
48K
|
Non-Energy Minerals
|
193.7%
|
O:
-0.65%
H:
2.1%
C:
-0.26%
NTNX
|
$59.88
1.92%
1.89%
2.2M
|
Technology Services
|
183.43%
|
O:
-0.47%
H:
2.95%
C:
-0.9%
NVAX
|
$4.09
3.02%
2.93%
2.3M
|
Health Technology
|
-78.08%
|
O:
-0.38%
H:
5.95%
C:
-1.62%
NBIX
|
News
M
|
$133.5
1.14%
1.12%
570K
|
Health Technology
|
30.07%
|
O:
0.27%
H:
3.81%
C:
3.08%
NFLX
|
$554.49
-0.1%
-0.1%
8.2M
|
Consumer Services
|
131.36%
|
O:
-1.13%
H:
2.3%
C:
-0.66%
MRNA
|
News
S
|
$104.48
3.03%
2.94%
3.1M
|
Health Technology
|
-11.53%
|
O:
0.31%
H:
3.5%
C:
-0.16%
MKSI
|
$109.71
1.42%
1.4%
680K
|
Electronic Technology
|
29.02%
|
O:
-1.59%
H:
1.55%
C:
-1.25%
awards
esg
growth
Biotechs Step Up Development Activities as U.S. Government Prioritizes Availability Of COVID-19 Vaccines
Published:
2021-03-15
(Crawled : 13:00)
- prnewswire.com
PFE
|
News
A
|
$26.26
1.0%
-0.08%
36M
|
Health Technology
|
-24.84%
|
O:
0.2%
H:
1.2%
C:
1.14%
JNJ
|
News
|
$149.12
0.82%
0.0%
9.3M
|
Health Technology
|
-6.57%
|
O:
0.09%
H:
0.57%
C:
0.42%
NVAX
|
$4.09
3.02%
2.93%
2.3M
|
Health Technology
|
-97.99%
|
O:
0.27%
H:
7.58%
C:
6.95%
MRNA
|
News
S
|
$104.48
3.03%
2.94%
3.1M
|
Health Technology
|
-23.75%
|
O:
-0.16%
H:
5.18%
C:
5.04%
BNTX
|
News
|
$88.01
1.38%
1.36%
390K
|
Health Technology
|
-14.79%
|
O:
0.69%
H:
4.0%
C:
3.74%
covid
biotech
vaccine
iot
covid-19
As India Burns Amid a Lethal 2nd Wave, It's Now Evident that the World Has Failed in Ensuring Equitable Access to Vaccines. While Vaccine Doses Reach 9.7 Billion by 2025, Will They be Equitably Distributed?
Published:
2021-05-20
(Crawled : 14:15)
- prnewswire.com
JNJ
|
News
|
$149.12
0.82%
0.0%
9.3M
|
Health Technology
|
-12.32%
|
O:
-0.08%
H:
0.97%
C:
0.66%
SNY
|
News
|
$47.125
1.78%
1.75%
2.1M
|
Health Technology
|
-12.44%
|
O:
1.32%
H:
1.12%
C:
0.92%
NVAX
|
$4.09
3.02%
2.93%
2.3M
|
Health Technology
|
-97.14%
|
O:
1.39%
H:
2.66%
C:
1.58%
MRNA
|
News
S
|
$104.48
3.03%
2.94%
3.1M
|
Health Technology
|
-33.88%
|
O:
1.22%
H:
4.31%
C:
3.78%
india
vaccine
Approximately 53% of Global Population to be Fully Vaccinated by the End of 2021
Published:
2021-09-02
(Crawled : 16:00)
- prnewswire.com
JNJ
|
News
|
$149.12
0.82%
0.0%
9.3M
|
Health Technology
|
-14.17%
|
O:
0.35%
H:
0.49%
C:
0.34%
SNY
|
News
|
$47.125
1.78%
1.75%
2.1M
|
Health Technology
|
-11.91%
|
O:
0.13%
H:
0.28%
C:
0.0%
NVAX
|
$4.09
3.02%
2.93%
2.3M
|
Health Technology
|
-98.39%
|
O:
0.15%
H:
3.58%
C:
2.59%
MRNA
|
News
S
|
$104.48
3.03%
2.94%
3.1M
|
Health Technology
|
-73.21%
|
O:
0.82%
H:
2.46%
C:
1.15%
vaccine
As Omicron Strain Fuels Fresh Waves of Infections Across the Globe, Mutating Coronavirus is the New Pandemic Challenge in 2022
Published:
2022-01-04
(Crawled : 17:00)
- prnewswire.com
JNJ
|
News
|
$149.12
0.82%
0.0%
9.3M
|
Health Technology
|
-12.36%
|
O:
0.51%
H:
0.0%
C:
0.0%
SNY
|
News
|
$47.125
1.78%
1.75%
2.1M
|
Health Technology
|
-8.69%
|
O:
-2.03%
H:
0.0%
C:
0.0%
NVAX
|
$4.09
3.02%
2.93%
2.3M
|
Health Technology
|
-97.15%
|
O:
-2.03%
H:
1.27%
C:
-1.11%
MRNA
|
News
S
|
$104.48
3.03%
2.94%
3.1M
|
Health Technology
|
-55.56%
|
O:
-1.15%
H:
0.0%
C:
0.0%
infection
infections
Global COVID-19 Vaccines Market Report 2022: Leading Vaccine Companies Stress on Booster Dose
Published:
2022-02-02
(Crawled : 21:00)
- prnewswire.com
JNJ
|
News
|
$149.12
0.82%
0.0%
9.3M
|
Health Technology
|
-12.3%
|
O:
1.26%
H:
0.0%
C:
0.0%
SNY
|
News
|
$47.125
1.78%
1.75%
2.1M
|
Health Technology
|
-11.21%
|
O:
-0.06%
H:
0.0%
C:
0.0%
NVAX
|
$4.09
3.02%
2.93%
2.3M
|
Health Technology
|
-95.64%
|
O:
-4.8%
H:
4.69%
C:
-0.33%
MRNA
|
News
S
|
$104.48
3.03%
2.94%
3.1M
|
Health Technology
|
-39.03%
|
O:
-3.66%
H:
3.05%
C:
-0.68%
covid-19
covid
report
vaccine
New Variants Throw the Spotlight on Booster Shots of COVID-19 Vaccines - According to New Research from StrategyR
Published:
2022-03-10
(Crawled : 15:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-6.65%
|
O:
2.52%
H:
1.67%
C:
1.67%
JNJ
|
News
|
$149.12
0.82%
0.0%
9.3M
|
Health Technology
|
-12.26%
|
O:
-0.85%
H:
0.0%
C:
0.0%
SNY
|
News
|
$47.125
1.78%
1.75%
2.1M
|
Health Technology
|
-9.3%
|
O:
-0.12%
H:
0.0%
C:
0.0%
NVAX
|
$4.09
3.02%
2.93%
2.3M
|
Health Technology
|
-94.85%
|
O:
-1.99%
H:
2.84%
C:
0.35%
MRNA
|
News
S
|
$104.48
3.03%
2.94%
3.1M
|
Health Technology
|
-26.69%
|
O:
-2.09%
H:
0.95%
C:
0.01%
covid-19
research
covid
vaccine
Influenza Pipeline Looks Promising as 100+ Companies Working in the Domain, Assesses DelveInsight
Published:
2022-08-31
(Crawled : 16:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
16.37%
|
O:
0.75%
H:
1.98%
C:
1.98%
SNY
|
News
|
$47.125
1.78%
1.75%
2.1M
|
Health Technology
|
12.35%
|
O:
1.1%
H:
0.0%
C:
0.0%
NVAX
|
$4.09
3.02%
2.93%
2.3M
|
Health Technology
|
-88.44%
|
O:
1.39%
H:
1.34%
C:
-7.48%
MRNA
|
News
S
|
$104.48
3.03%
2.94%
3.1M
|
Health Technology
|
-23.15%
|
O:
0.75%
H:
2.14%
C:
-3.42%
CDTX
|
News
|
$0.5135
-24.6%
-32.62%
3.7M
|
Health Technology
|
-26.69%
|
O:
1.15%
H:
0.0%
C:
-3.37%
companies
influenza
Novavax Appoints Vaccine Industry Expert Margaret G. McGlynn to Board of Directors
Published:
2020-12-09
(Crawled : 13:03)
- globenewswire.com
NVAX
|
$4.09
3.02%
2.93%
2.3M
|
Health Technology
|
-96.61%
|
O:
2.91%
H:
0.11%
C:
-6.8%
vaccine
Novavax Announces Agreement with Government of New Zealand for 10.7 Million Doses of COVID-19 Vaccine
Published:
2020-12-17
(Crawled : 01:00)
- globenewswire.com
NVAX
|
$4.09
3.02%
2.93%
2.3M
|
Health Technology
|
-96.63%
|
O:
2.98%
H:
6.57%
C:
5.84%
vaccine
covid
covid-19
Novavax Announces Agreement with Government of New Zealand for 10.7 Million Doses of COVID-19 VaccineAdvance purchase agreement signed for NVX-CoV2373, Novavax’ adjuvanted protein vaccine candidate
Published:
2020-12-17
(Crawled : 06:00)
- biospace.com/
NVAX
|
$4.09
3.02%
2.93%
2.3M
|
Health Technology
|
-96.63%
|
O:
2.98%
H:
6.57%
C:
5.84%
vaccine
covid
nvx-cov2373
Novavax to Participate in Upcoming Conferences
Published:
2021-01-06
(Crawled : 14:03)
- globenewswire.com
NVAX
|
$4.09
3.02%
2.93%
2.3M
|
Health Technology
|
-96.5%
|
O:
-0.63%
H:
7.57%
C:
7.12%
conference
Biopharma Executive Rick Crowley Joins Novavax as Chief Operations Officer
Published:
2020-12-21
(Crawled : 23:00)
- globenewswire.com
NVAX
|
$4.09
3.02%
2.93%
2.3M
|
Health Technology
|
-96.72%
|
O:
-0.11%
H:
0.34%
C:
-6.9%
biopharma
risk
Novavax Announces Initiation of PREVENT-19 Pivotal Phase 3 Efficacy Trial of COVID-19 Vaccine in the United States and Mexico
Published:
2020-12-28
(Crawled : 15:00)
- globenewswire.com
NVAX
|
$4.09
3.02%
2.93%
2.3M
|
Health Technology
|
-96.85%
|
O:
-0.07%
H:
0.58%
C:
-9.59%
covid
vaccine
phase 3
trial
Novavax Finalizes Agreement with Commonwealth of Australia for 51 Million Doses of COVID-19 Vaccine
Published:
2021-01-07
(Crawled : 00:00)
- globenewswire.com
NVAX
|
$4.09
3.02%
2.93%
2.3M
|
Health Technology
|
-96.82%
|
O:
1.37%
H:
5.88%
C:
-6.22%
covid
vaccine
covid-19
← Previous
1
2
3
4
5
6
7
8
9
10
11
12
Next →
Gainers vs Losers
75%
25%
Top 10 Gainers
MTTR
|
News
M
|
$4.78
174.71%
63.6%
72M
|
AGBA
|
$2.565
105.2%
51.27%
200M
|
Finance
MLEC
|
$2.44
74.29%
42.62%
78M
|
n/a
EDBL
|
News
|
$6.28
67.02%
40.13%
16M
|
ATGL
|
$2.91
48.81%
32.8%
180K
|
ZAPP
|
$0.2175
47.16%
32.05%
16M
|
n/a
ONFO
|
$0.6075
38.38%
27.74%
7.3M
|
n/a
VIVK
|
$1.48
38.32%
27.7%
530K
|
Professional, Scientific, and T...
MNTS
|
$0.5
35.69%
26.3%
4.8M
|
SDIG
A
|
$3.635
35.13%
26.0%
1M
|
Your saved searches
Save your searches and get alerts when important news are released.